$阿瑪琳(AMRN.US)$Reported Saturday, New REDUCE-IT Analyses By Amarin Show That VASCEPA/VAZKEPA Benefits High-Risk Cardiovascular Disease Patient Subgroups
$阿瑪琳(AMRN.US)$Amarin Received Decision To Grant From European Patent Office For New Patent Covering VAZKEPA That Will Extend VAZKEPA Exclusivity Eight Additional Years Into 2039
$阿瑪琳(AMRN.US)$Officer Holt Patrick purchased 14,426 shares of Common Stocks on Jan 22, 2024 at an average price of $1.09 for a total value of $15,724.34.
Amarin's low P/S ratio is due to declining revenue and expectations of below-average growth. Lack of investor confidence in future revenue growth may further affect its share price if no improvements are made.
阿瑪琳股票討論區
Keep your eyes on!
Update
Update! Nice!
Insider buy
I kinda like this one.
News
Moomoo 24/7· 1 min ago
Going in big now
暫無評論